Bank of New York Mellon Corp Sells 58,646 Shares of Privia Health Group, Inc. $PRVA

Bank of New York Mellon Corp reduced its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 2.7% in the second quarter, HoldingsChannel.com reports. The firm owned 2,152,558 shares of the company’s stock after selling 58,646 shares during the period. Bank of New York Mellon Corp’s holdings in Privia Health Group were worth $49,509,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Van Berkom & Associates Inc. bought a new position in Privia Health Group during the 1st quarter valued at approximately $45,207,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Privia Health Group by 180.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock valued at $59,112,000 after acquiring an additional 1,693,870 shares in the last quarter. Nuveen LLC bought a new position in shares of Privia Health Group during the first quarter valued at approximately $26,899,000. Royce & Associates LP purchased a new stake in Privia Health Group in the first quarter worth $6,818,000. Finally, Cinctive Capital Management LP boosted its holdings in Privia Health Group by 82.2% in the first quarter. Cinctive Capital Management LP now owns 253,783 shares of the company’s stock valued at $5,697,000 after acquiring an additional 114,478 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA opened at $24.32 on Wednesday. The company has a 50 day simple moving average of $24.18 and a two-hundred day simple moving average of $22.77. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The company has a market capitalization of $2.99 billion, a price-to-earnings ratio of 187.09, a P/E/G ratio of 3.32 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The firm had revenue of $213.61 million for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%. On average, analysts forecast that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on PRVA shares. Weiss Ratings raised shares of Privia Health Group from a “sell (d+)” rating to a “hold (c)” rating in a research report on Friday. Stephens reissued an “overweight” rating and issued a $32.00 price target on shares of Privia Health Group in a research note on Wednesday, September 24th. Citigroup restated an “outperform” rating on shares of Privia Health Group in a report on Friday, August 29th. Truist Financial reiterated a “buy” rating and set a $31.00 target price (up previously from $30.00) on shares of Privia Health Group in a report on Monday. Finally, Evercore ISI raised their target price on Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $29.58.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.